PROS1 and prostate carcinoma: As a result, the glycobiosensor could detect PSA glycoprotein in serum in a linear range of 100 ag mL−1 to 1 μg mL−1 with a LOD of 100 ag mL−1 and discriminated serum samples from healthy individuals of prostate cancer patients [155].